Structure Therapeutics, Inc. (GPCR)
21.76
+0.68
(+3.23%)
USD |
NASDAQ |
Oct 19, 13:55
Structure Therapeutics Cash from Operations (Annual) : -222.79M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -222.79M |
| December 31, 2024 | -116.69M |
| December 31, 2023 | -79.42M |
| Date | Value |
|---|---|
| December 31, 2022 | -46.07M |
| December 31, 2021 | -32.20M |
| December 31, 2020 | -14.31M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Eli Lilly & Co. | 16.81B |
| Novo Nordisk A/S | 18.01B |
| Pfizer Inc. | 11.70B |
| Viking Therapeutics, Inc. | -278.68M |
| Liquidia Corp. | -35.69M |